Aclidinium Bromide: Clinical Benefit in Patients with Moderate to Severe COPD
about
Aclidinium bromide for the treatment of chronic obstructive pulmonary diseaseCombined aclidinium bromide and long-acting beta 2 -agonist for COPDAclidinium bromide for stable chronic obstructive pulmonary diseaseEfficacy and Safety of an Aclidinium Bromide Treatment for 12 Weeks or Longer in Patients with Moderate-To-Severe COPD: A Meta-Analysis.Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.Once-daily glycopyrronium via the Breezhaler® device for the treatment of COPD: pharmacological and clinical profile.Drug-target residence time--a case for G protein-coupled receptors.Once-daily glycopyrronium bromide (Seebri Breezhaler(®)) for the treatment of chronic obstructive pulmonary disease (COPD).
P2860
Q22306019-6B3F630C-B743-431A-85E1-7529EA9BD4D8Q24187613-FB12588D-8A01-4E48-B852-B0E68AB3B67AQ24193506-077EAF3C-B616-4259-BF13-55EDF33BE495Q35914818-3A865BEF-260A-47B3-B78A-3C693E05E3DFQ37177278-58CC9291-BF25-4763-AC0C-DF5658B71C97Q38131050-F6A04960-0D47-45C4-BE68-0C9E1F44A8F3Q38189272-E7CC8483-B024-4209-A0BC-B6BF3CC1CCF0Q38660895-57FD2D2D-C4C2-4815-9142-F4A214C2B2BC
P2860
Aclidinium Bromide: Clinical Benefit in Patients with Moderate to Severe COPD
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Aclidinium Bromide: Clinical Benefit in Patients with Moderate to Severe COPD
@en
type
label
Aclidinium Bromide: Clinical Benefit in Patients with Moderate to Severe COPD
@en
prefLabel
Aclidinium Bromide: Clinical Benefit in Patients with Moderate to Severe COPD
@en
P2860
P1476
Aclidinium Bromide: Clinical Benefit in Patients with Moderate to Severe COPD
@en
P2093
Charlotte Suppli Ulrik
P2860
P304
P356
10.2174/1874306401206010150
P577
2012-12-14T00:00:00Z